Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

M Charts Versus Amsler Test in Evaluating Metamorphopsia in Neovascular AMD Patients Treated With Anti-VEGF

NCT05324150 is registered in ClinicalTrials.gov with Ospedale Santa Croce-Carle Cuneo as lead sponsor.

NCT NCT05324150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05324150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
M Charts Versus Amsler Test in Evaluating Metamorphopsia in Neovascular AMD Patients Treated With Anti-VEGF
Lead sponsor
Ospedale Santa Croce-Carle Cuneo
Phase
Observational
Overall status
Completed
Start date
May 9, 2022
Completion date
September 30, 2023
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

macular degeneration, wet, metamorphopsia